In accordance with the ‘Drug Approval Change Order’ (Drug Safety Evaluation Division-No. 6974, effective date 2017. 12. 01), the precautions for use of Amoctin Tablet 375 mg have been changed.


For further details, please refer to the ‘Product Introduction’ section and attached documents.